Jingqing Mu

426 total citations
20 papers, 355 citations indexed

About

Jingqing Mu is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Jingqing Mu has authored 20 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomaterials, 8 papers in Biomedical Engineering and 7 papers in Molecular Biology. Recurrent topics in Jingqing Mu's work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (6 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Jingqing Mu is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (6 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Jingqing Mu collaborates with scholars based in China, Iran and United States. Jingqing Mu's co-authors include Shutao Guo, Haiping Zhong, Na Yu, Zunkai Xu, Xing‐Jie Liang, Yang Xu, Ziqi Chen, Qiankun Ni, Xi Zhang and Ziqi Chen and has published in prestigious journals such as Nature Communications, Nano Letters and Chemical Engineering Journal.

In The Last Decade

Jingqing Mu

20 papers receiving 350 citations

Peers

Jingqing Mu
Comparison fields: 5 of 79
  • Biomedical Engineering 147
  • Molecular Biology 136
  • Biomaterials 132
  • Materials Chemistry 40
  • Oncology 31
Ana Cláudia Lima Portugal
Wenya Zhou China
Tangna Hao China
Haitao Ding China
Ganesh Vambhurkar India
Meng-Ya Chang Taiwan
Lingran Du China
Xi Tan China
Shivani Saraf India
Khan Asifullah China
Ana Cláudia Lima Portugal View profile →
Citations per field, relative to Jingqing Mu
Jingqing Mu · 1×
Citations per year, relative to Jingqing Mu
Jingqing Mu · 1×

Countries citing papers authored by Jingqing Mu

Since Specialization
Citations

This map shows the geographic impact of Jingqing Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingqing Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingqing Mu more than expected).

Fields of papers citing papers by Jingqing Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingqing Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingqing Mu. The network helps show where Jingqing Mu may publish in the future.

Co-authorship network of co-authors of Jingqing Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingqing Mu. A scholar is included among the top collaborators of Jingqing Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingqing Mu. Jingqing Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Responsive Microneedles for Diagnostic and Therapeutic Applications of Ocular Diseases Small Methods Jingqing Mu, Xiangyu Ding et al. 2
2 From tradition to innovation: Systematic analysis of quality markers (Q-markers) in traditional Chinese medicine Chinese Journal of Analytical Chemistry Jingqing Mu, Hongwei Li et al. 2
3 Tumor-penetrating iRGD facilitates penetration of poly(floxuridine-ketal)-based nanomedicine for enhanced pancreatic cancer therapy Journal of Controlled Release Haiping Zhong, Shujing Zheng et al. 14
4 Subconjunctival injection of microcrystalline prodrug of dexamethasone for long-acting anti-inflammation after phacoemulsification surgery Journal of Controlled Release Zunkai Xu, Zhixia Chen et al. 2
5 Drug content on anticancer efficacy of self-assembling ketal-linked dextran-paclitaxel conjugates Journal of Controlled Release Haiping Zhong, Jingqing Mu et al. 14
6 Fine-tuning the sequential drug release of nano-formulated mutual prodrugs dictates the combination effects Chemical Science Haiping Zhong, Na Yu et al. 8
7 PDLLA length on anti-breast cancer efficacy of acid-responsive self-assembling mPEG-PDLLA‒docetaxel conjugates Chinese Chemical Letters Jingqing Mu, Xi Zhang et al. 9
8 Type I Collagen‐Adhesive and ROS‐Scavenging Nanoreactors Enhanced Retinal Ganglion Cell Survival in an Experimental Optic Nerve Crush Model Macromolecular Rapid Communications Jingqing Mu, Xiaoyong Yuan et al. 5
9 Collagen-anchored cascade nanoreactors with prolonged intratumoral retention for combined cancer starvation and chemotherapy Chemical Engineering Journal Jingqing Mu, Haiping Zhong et al. 29
10 Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy Nano Letters Na Yu, Xi Zhang et al. 15
11 Determination of four parabens in cosmetics by high-performance liquid chromatography with magnetic solid-phase and ionic dispersive liquid–liquid extraction Reviews in Analytical Chemistry Xun Gao, Kexin Chen et al. 9
12 Modular ketal-linked prodrugs and biomaterials enabled by organocatalytic transisopropenylation of alcohols Nature Communications Na Yu, Yang Xu et al. 25
13 A Metabonomics Study of Guan-Xin-Shu-Tong Capsule against Diet-Induced Hyperlipidemia in Rats Russian Journal of Bioorganic Chemistry Xun Gao, Jingqing Mu et al. 1
14 Acid-Triggered Release of Native Gemcitabine Conjugated in Polyketal Nanoparticles for Enhanced Anticancer Therapy Biomacromolecules Haiping Zhong, Jingqing Mu et al. 33
15 Acid-sensitive PEGylated paclitaxel prodrug nanoparticles for cancer therapy: Effect of PEG length on antitumor efficacy Journal of Controlled Release Jingqing Mu, Haiping Zhong et al. 54
16 Acid-sensitive PEGylated cabazitaxel prodrugs for antitumor therapy Chinese Chemical Letters Tao Liu, Jingqing Mu et al. 22
17 Modular Acid-Activatable Acetone-Based Ketal-Linked Nanomedicine by Dexamethasone Prodrugs for Enhanced Anti-Rheumatoid Arthritis with Low Side Effects Nano Letters Yang Xu, Jingqing Mu et al. 79
18 Vortex‐ultrasound‐assisted dispersive liquid–liquid microextraction coupled with gas chromatography–mass spectrometry for the analysis of volatile bioactive components and comparative pharmacokinetic study of the herb–herb interactions in Guanxin Shutong Capsule Journal of Separation Science Jingqing Mu, Xun Gao et al. 12
19 Simultaneous determination of phenolic acids and diterpenoids and their comparative pharmacokinetic study in normal and acute blood stasis rats by UFLC–MS/MS after oral administration of Guan-Xin-Shu-Tong capsules Journal of Chromatography B Xun Gao, Jingqing Mu et al. 10
20 Comprehensive Identification of Guan-Xin-Shu-Tong Capsule via a Mass Defect and Fragment Filtering Approach by High Resolution Mass Spectrometry: In Vitro and In Vivo Study Molecules Xun Gao, Jingqing Mu et al. 10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026